GABA Promoter and PDE4 Inhibitor in the Management of Polycystic Ovary Syndrome: A Nutraceutical Approach.

Key Points

• The aim is to investigate the potential of dietary modulation in managing polycystic ovary syndrome (PCOS) through GABA and PDE4 inhibitors.
• Reviewed dietary interventions targeting inflammatory and neuroendocrine pathways.
• Discussed the roles of GABA and PDE4 inhibitors as complementary treatments.
• Highlighted the need for further clinical trials to validate findings.
• Suggests a promising approach to PCOS management using nutraceuticals.
• Indicates a potential reduction in symptoms through dietary modulation.
• Emphasizes the requirement for more research to ensure safety and efficacy.